Search Results - "Tan, Tuan Zea"
-
1
ASLAN003, a potent dihydroorotate dehydrogenase inhibitor for differentiation of acute myeloid leukemia
Published in Haematologica (Roma) (01-09-2020)“…Differentiation therapies achieve remarkable success in acute promyelocytic leukemia, a subtype of acute myeloid leukemia. However, excluding acute…”
Get full text
Journal Article -
2
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma
Published in Nature communications (22-03-2019)“…Liposarcomas (LPSs) are a group of malignant mesenchymal tumors showing adipocytic differentiation. Here, to gain insight into the enhancer dysregulation and…”
Get full text
Journal Article -
3
BET Bromodomain inhibition promotes De-repression of TXNIP and activation of ASK1-MAPK pathway in acute myeloid leukemia
Published in BMC cancer (11-07-2018)“…Targeted therapy has always been the focus in developing therapeutic approaches in cancer, especially in the treatment of acute myeloid leukemia (AML). A new…”
Get full text
Journal Article -
4
Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation
Published in Nature communications (29-04-2020)“…Gain of function (GOF) DNA binding domain (DBD) mutations of TP53 upregulate chromatin regulatory genes that promote genome-wide histone methylation and…”
Get full text
Journal Article -
5
The role of GRHL2 and epigenetic remodeling in epithelial–mesenchymal plasticity in ovarian cancer cells
Published in Communications biology (24-07-2019)“…Cancer cells exhibit phenotypic plasticity during epithelial–mesenchymal transition (EMT) and mesenchymal–epithelial transition (MET) involving intermediate…”
Get full text
Journal Article -
6
SNAI1-Driven Sequential EMT Changes Attributed by Selective Chromatin Enrichment of RAD21 and GRHL2
Published in Cancers (02-05-2020)“…Over two decades of research on cancer-associated epithelial-mesenchymal transition (EMT) led us to ascertain the occurrence of transitional intermediate…”
Get full text
Journal Article -
7
Disruption of Runx1 and Runx3 Leads to Bone Marrow Failure and Leukemia Predisposition due to Transcriptional and DNA Repair Defects
Published in Cell reports (Cambridge) (07-08-2014)“…The RUNX genes encode transcription factors involved in development and human disease. RUNX1 and RUNX3 are frequently associated with leukemias, yet the basis…”
Get full text
Journal Article -
8
A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinoma
Published in Nature communications (25-03-2020)“…c-MET receptors are activated in cancers through genomic events like tyrosine kinase domain mutations, juxtamembrane splicing mutation and amplified copy…”
Get full text
Journal Article -
9
Pharmacological Inhibition of TFF3 Enhances Sensitivity of CMS4 Colorectal Carcinoma to 5-Fluorouracil through Inhibition of p44/42 MAPK
Published in International journal of molecular sciences (09-12-2019)“…Increased expression of trefoil factor 3 (TFF3) has been reported in colorectal carcinoma (CRC), being correlated with distant metastasis and poor clinical…”
Get full text
Journal Article -
10
The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions
Published in Human pathology (01-01-2015)“…Summary We recently identified gene signatures that allow classification of ovarian carcinoma into 5 distinct clinically relevant groups. In the present study,…”
Get full text
Journal Article -
11
E74 like ETS transcription factor 3 (ELF3) is a negative regulator of epithelial- mesenchymal transition in bladder carcinoma
Published in Cancer biomarkers : section A of Disease markers (01-01-2019)“…Transcription factors are commonly deregulated in various cancers. Here, we evaluated role of ELF3 in pathogenesis of bladder carcinoma (BCa). We confirmed…”
Get more information
Journal Article -
12
LIN28B Activation by PRL-3 Promotes Leukemogenesis and a Stem Cell-like Transcriptional Program in AML
Published in Molecular cancer research (01-03-2017)“…PRL-3 (PTP4A3), a metastasis-associated phosphatase, is also upregulated in patients with acute myeloid leukemia (AML) and is associated with poor prognosis,…”
Get full text
Journal Article -
13
Epithelial-to-Mesenchymal Transition is a Cause of Both Intrinsic and Acquired Resistance to KRAS G12C Inhibitor in KRAS G12C-Mutant Non-Small Cell Lung Cancer
Published in Clinical cancer research (15-11-2020)“…is among the most commonly mutated oncogene in cancer including non-small cell lung cancer (NSCLC). In early clinical trials, inhibitors targeting G12C-mutant…”
Get full text
Journal Article -
14
Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancers
Published in Cell death discovery (27-09-2021)“…Clinical trials repurposing peroxisome proliferator-activated receptor-gamma (PPARγ) agonists as anticancer agents have exhibited lackluster efficacy across a…”
Get full text
Journal Article -
15
Dual role of autophagy in hallmarks of cancer
Published in Oncogene (01-03-2018)“…Evolutionarily conserved across eukaryotic cells, macroautophagy (herein autophagy) is an intracellular catabolic degradative process targeting damaged and…”
Get full text
Journal Article -
16
Epithelial‐mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients
Published in EMBO molecular medicine (01-10-2014)“…Epithelial‐mesenchymal transition (EMT) is a reversible and dynamic process hypothesized to be co‐opted by carcinoma during invasion and metastasis. Yet, there…”
Get full text
Journal Article -
17
A Novel Biologically and Psychologically Inspired Fuzzy Decision Support System: Hierarchical Complementary Learning
Published in IEEE/ACM transactions on computational biology and bioinformatics (01-01-2008)“…A computational intelligent system that models the human cognitive abilities may promise significant performance in problem learning because a human is…”
Get full text
Journal Article -
18
The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200
Published in Oncoimmunology (02-01-2017)“…PD-L1 expression and regulation by mesenchymal tumor cells remain largely undefined. Here, we report that among different EMT-activated MCF7 human breast…”
Get full text
Journal Article -
19
Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis
Published in Cancers (14-04-2021)“…In cancer cells, a vital cellular process during metastasis is the transformation of epithelial cells towards motile mesenchymal cells called the epithelial to…”
Get full text
Journal Article -
20
SNAI1 recruits HDAC1 to suppress SNAI2 transcription during epithelial to mesenchymal transition
Published in Scientific reports (05-06-2019)“…Aberrant activation of epithelial to mesenchymal transition (EMT) associated factors were highly correlated with increased mortality in cancer patients. SNAIL…”
Get full text
Journal Article